SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-005397
Filing Date
2004-01-29
Accepted
2004-01-29 14:42:09
Documents
1
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION boh12032_3sm.html 5  
1 MAIN DOCUMENT DESCRIPTION boh12032_3sm.xml 5 3111
  Complete submission text file 0001209191-04-005397.txt   5307
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 EAST 70TH ST APT 6D NEW YORK NY 10021
Business Address 330 EAST 70TH ST APT 6D NEW YORK NY 10021 2125702595
MORRELL STEVEN (Reporting) CIK: 0001254525 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31564 | Film No.: 04551930